Ironwood Pharmaceuticals (IRWD) Interest & Investment Income (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Interest & Investment Income across 17 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 93.77% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $5.7 million (up 56.82% YoY), while the FY2025 annual figure was $4.1 million, down 8.77% from the prior year.
• Interest & Investment Income came in at $1.6 million for Q2 2026 at Ironwood Pharmaceuticals, down from $1.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.8 million in Q2 2023 to a low of $230000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $2.2 million, with a median of $1.3 million recorded in 2023.
• Year-over-year, Interest & Investment Income surged 3061.74% in 2023 and sank 84.37% in 2024.
• Over 5 years, Interest & Investment Income stood at $5.4 million in 2022, then sank by 78.08% to $1.2 million in 2023, then sank by 34.84% to $778000.0 in 2024, then soared by 87.53% to $1.5 million in 2025, then gained by 8.64% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.6 million in Q2 2026, $1.7 million in Q1 2026, and $1.5 million in Q4 2025.